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OBJECTIVES: To create a profile of individuals nonadherent 
to their medications in an age-stratified sample (ages 34-84) 
of community-dwelling rheumatoid arthritis patients. The 
relative contributions of age, cognitive function, disability, 
emotional state, lifestyle, and beliefs about illness to nonad- 
herence were assessed. 
DESIGN: A direct observation approach was used in con- 
junction with structural equation modeling. All participants 
were administered a preliminary assessment battery. Medica- 
tions were then transferred to vials with microelectronic caps 
that recorded medication events for all medications for the 
next 4 weeks. 
PARTICIPANTS AND SETTING: A volunteer sample of 
121 community-dwelling rheumatoid arthritis (RA) patients 
were recruited from newspaper ads, posters, and via informal 
physician contact from private rheumatology practices in 
Atlanta and Athens, Georgia. Written verification of the RA 
diagnosis and a disease severity rating were obtained from 
personal physicians before patients were enrolled in the 
study. Patients were tested in a private physician's office, and 
their medication adherence was monitored electronically for 
a month in their every-day work and home settings. 
MEASUREMENTS AND RESULTS: Structural equation 
modeling techniques were used to develop a model of adher- 
ence behavior. Cognitive and psychosocial measures were 
used to construct latent variables to predict adherence errors. 
The model of medication adherence explained 39% of the 
variance in adherence errors. The model demonstrated that 
older adults made the fewest adherence errors, and middle- 
aged adults made the most. A busy lifestyle, age, and cogni- 
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tive deficits predicted nonadherence, whereas coping with 
arthritis-related moods predicted adherence. Illness severity, 
medication load, and physical function did not predict adher- 
ence errors. Omission of medication accounted for nearly all 
errors. 
CONCLUSION Despite strong evidence for normal, age- 
related cognitive decline in this sample, older adults had 
sufficient cognitive function to manage medications. A busy 
lifestyle and middle age were more determinant of who was at  
risk of nonadherence than beliefs about medication or illness. 
Thus, practicing physicians should not assume that older 
adults have insufficient cognitive resources to manage medi- 
cations and that they will be thc most likely to make adher- 
ence errors. Very busy middle-aged adults seem to be at  the 
greatest risk of managing medications improperly. J Am 
Geriatr SOC 42172-183,1999. 
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critical element in successful clinical treatment of a A disorder is that patients take the medication that is 
prescribed for them. It is widely believed that nonadherence is 
a serious problem, with particularly high estimates of nonad- 
herence for older adults' and for individuals with chronic 
diseases such as rheumatoid arthritis (RA).2-4 Recent ad- 
vances in microelectronic monitoring have provided good 
measurement of adherence behaviors. The Medication Event 
Monitoring System (MEMS) relies on microchip technology 
that provides detailed records about thc frequency with 
which a medication bottle is opened, thus providing more 
accurate data than has been available in the past about 
medication-taking behaviors over long periods of time. The 
available data suggest that MEMS provides lower estimates 
of adherence behaviors than verbal reports or pill counts, in 
part because the timing of ingestion is measured precisely.s16 
Less clear from such data are the causes of nonadher- 
ence. Medication adherence is a complex behavior that is 
likely affected by patients' beliefs about their illness, the 
complexity of their medication regimen, their overall level of 
cognitive function, the severity of their illness, and even the 
nature of their One might expect, for example, that 
a highly adherent individual would be a younger person, with 
a high level of cognitive ability, who was seriously ill, believed 
JAGS 47:172-183,1999 
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him/herself to be very ill, and had an illness that provided 
feedback about the condition, such as pain or rapid heart 
beat. In contrast, a less adherent individual might be an older 
adult who was unconcerned about the diagnosis of an illness, 
received little physical feedback regarding the disorder, as in 
the case of hypertension, and had limited cognitive resources 
for managing a complex medication regimen. Finally, the 
environment itself may contribute to nonadherence in that 
we often forget to perform important actions when we are 
very busy’; thus, individuals who have many demands on 
their time might also be at  high risk of nonadherence. 
Thc above analysis suggests that multiple variables con- 
tribute to medication nonadherence and that an understand- 
ing of its causes is likely to be incomplete if an exclusively 
medical, cognitive, or psychosocial approach is taken. Struc- 
tural equation modeling pcrmits one to evaluate the joint 
contributions of causative agents to a behavior. We used 
structural equation modeling in the present rescarch to assess 
the relative contributions of age, cognitive function, beliefs 
about illness, objective health status, life style, and affective 
state to medication adherence. Each of these domains (except 
busy lifestyle) has already been studied separately as a cause 
of nonadherence. 
Leventhal and Cameron” focus on beliefs and suggest 
that medication adherence is a self-regulatory process based 
on a patient’s perceptions and beliefs about their illness. In 
support of this model, Taal et al.” reported that beliefs about 
self-efficacy were related to good self-reports of adherence 
and coping with RA. 
Park,12 on the other hand, has proposed a cognitive 
model and has suggested that age and declining cognitive 
ability are factors that may directly affect adherence or may 
underlie faulty representations that encourage nonadherence. 
There is little evidence in regard to this issue. Isaac, Tamblyn, 
and the McGill-Calgary Drug Research TeamI3 reported 
limited correlations between cognitive function and adher- 
ence in a sample of older subjects, but the sample consisted of 
only 20 adults, with a variety of disorders, and the observed 
relationships were weak. Conn et aI.l4 reported no difference 
in adherence in aged individuals with low and high Mini- 
Mental State Exam scores.’’ Finally, others have taken a 
medical approach and have argued that medication load and 
illness severity arc of primary importance in understanding 
who is nonadherent rather then focusing on beliefs or cogni- 
tion.16-’’ 
Unlike the earlier studies, the present investigation ex- 
amined all of these causative factors together as potential 
determinants of thc medication adherence of rheumatoid 
arthritis patients. We were particularly interested in the hy- 
pothesis that declining cognitive abilities that occur with age 
in normal, community-dwelling older adults may result in 
poor adherence to a medication regimen. For this reason, we 
selected an illness for which we expected adherence to be 
relatively good. Rheumatoid arthritis is a serious, debilitating 
autoimmune disorder that can be treated effectively with 
immunosuppressants, corticosteroids, and nonsteroidal anti- 
inflammatory drugs. RA patients experience pain that can be 
managed with adherence to medications. They also often 
have a number of concomitant conditions and are typically 
on a high medication load. These considerations led us to 
believe that RA patients would be highly motivated to adhere 
to a medication regimen so that age-related cognitive decline 
would be likely to be a salient factor in any observed nonad- 
herence. 
METHODS 
Study Design 
We used a direct observation or survey approach to 
study adherence and the predictors of adherence. At the 
beginning of the study, a comprehensive assessment survey 
measured patients’ cognitive function, self-reportcd health, 
affective state, beliefs about their arthritis and medications, 
functional capabilities, and pain. After this initial assessment, 
each one of the participants’ medications was transferred to a 
separate medication vial outfitted with the MEMS technol- 
ogy. Patients used the MEMS vials for 4 weeks, and the date 
and time that each medication vial was opened was recorded 
via a microchip contained in the lid. When the patients 
returned at  the end of 4 weeks, the information in the medi- 
cation lids was downloaded into a computer file, providing a 
detailed record of medication-taking behavior for each med- 
ication. 
Sample 
Of the 122 community-dwelling individuals, aged 34 to 
84, diagnosed with RA and recruitcd to be in the study, a 
total of 121 (100 women and 21 men) participated in the 
study. Only one dropped out, because of transportation 
difficulties; all others completed the entire protocol. Partici- 
pants were recruited from newspaper advertisements, posters 
placed in physicians’ offices, and patient organizations. All 
potential participants provided a written diagnosis of RA 
from their personal physician before being admitted to the 
study. The participant’s personal physician also provided a 
severity rating of the arthritis using the Arthritis Founda- 
tion’’ rating scale from 1 (mild) to 5 (severe). Patients wcre 
taking a minimum of four prescribed medications, at  least 
one of which was for RA and at  least three of which had to be 
taken on a daily basis. The remaining medication could have 
been taken on an “as needed” basis. In addition, patients had 
a minimum eighth grade education, 20/30 corrected vision, 
and could also hear sufficiently well to converse normally on 
the phone with an interviewer during the initial screening 
interview. Patients had to be willing to come to an off-site 
testing station in a privatc physician’s office in Atlanta or 
Athens, Georgia. Any individual who had bcen hospitalized 
in the past 6 months or who reported receiving assistance 
managing their medications was excluded. The Institutional 
Review Board at  the University of Georgia approved this 
project, and written informed consent was obtained from the 
participants at  the beginning of their first meeting with the 
experimenters. Individuals were paid $100 for their partici- 
pation. All payments to participants were completed after 2 
weeks of the 4-weck participation. 
The participants were well educated; 96% had com- 
pleted high school, and 66% had completed some college. 
Participants were taking a mean of 4.18 prescription medica- 
tions on a daily basis, and both physicians and patients rated 
their rheumatoid arthritis as “moderate” on a 5-point sever- 
ity scale (means of 3.18 for patients and 3.20 for physicians), 
with no differences between patient and physician ratings. A 
mean of 25.9 symptoms and conditions was reported on the 
Medical History Checklist out of a possible total of 72 that 
could be reported on this assessment of all bodily systems.” 
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Table 1 summarizes basic participant characteristics across 
five age groups; there are no differences across these groups 
for symptoms, number of prescription medications, years 
since diagnosis, education, self-rated or physician-rated dis- 
ease severity, and/or self-reported disability as measured by 
subscales from the Revised and Expanded Arthritis Impact 
Measure Scales Health Status Questionnaire (AIMS2).2’ The 
six subscales of the AIMS2 that were assessed were mobility, 
walking and bending, hand and finger function, arm func- 
tion, self-care tasks, and household tasks. Comparison of 
participants’ mean levels of disability with the Meenan et 
aL2* standardization sample for the AIMS2 allowed us to 
evaluate the relative functioning of our sample compared 
with these normative data. Results from large-sample statis- 
tical tests for mean differences between these groups indi- 
cated that the present sample was significantly younger (z  = 
3.32, P < .Ol), and more mobile ( z  = 3.14, P < .01) and 
better able to perform self-care and household tasks (z  = 
2.63, P < .05, z = 3.10, P < .05, respectively) than the 
sample from the AIMS2. These data are presented in Table 2. 
Inasmuch as participants had to be sufficiently mobile to visit 
the field office for the assessment sessions, these differences 
were not surprising. 
Assessment Battery 
The instruments that patients completed are described 
below. All required multiple choice responses or Likert-scale 
checkoffs unless otherwise noted. The instruments were pre- 
sented on computer screens, which participants completed by 
pressing designated buttons on a computer keyboard. This 
was less fatiguing for patients than writing and required less 
manual dexterity. As in our previous research, participants 
were enthusiastic about the computer, and even the oldest 
adapted easily.22 Screen displays were printed in large char- 
acters. All software was designed by a professional consulting 
agency to be suitable for use with older adults. 
Derrrographic Questionnaire 
A modified version of the OARS23 was used to obtain 
information on gender, age, education, profession, living 
arrangements, and income. 
Table 2. Average Scores and Standard Deviations on AIMS2 
Functioning and Pain Variables of Prcsent Sample Compared 
with Meenan et al. (1992) Sample 
Present Meenan 
Sample Sample 
Variable (n = 120) (n = 299) 
Age 56.07 (12.74)* 60.70 (13.3) 
Mobility 1.11 (1.41) 1.69 (2.28) 
Walking and bending 4.21 (2.46) 4.58 (2.83) 
Hand and finger function 2.81 (2.28) 3.1 6 (2.58) 
Arm function 1.85 (2.09) 2.01 (2.26) 
Self-care tasks 0.36 (1.20) 0.73 (1.53) 
Household tasks 1.06 (1.51) 1.67 (2.43) 
Pain 4.99 (2.51) 4.69 (2.52) 
Note: All AIMS2 items and scales were scored such that low scores indicate good 
health status whereas high scores indicate poor health status. Scale scores were 
calculated by summing the responses for all items in a particular scale. All scale 
scores were then standardized so that the best possible scale score was 0 and the 
worst possible score was 10. 
‘Standard Deviations are shown in parentheses. 
Health and Function 
Health Inventory. Participants were asked to check off 
items from a detailed list of past conditions and to present 
symptoms derived from the Medical Inventory Checklist.” A 
total sum of items checked, as well as a weighted sum (with 
more serious symptoms and conditions given greater weight) 
was obtained. 
Arthritis Pain, Stiffness, and Fatigue. An instrument 
modeled on the pain subscale of the AIMS221 provided an 
additional assessment of pain caused by arthritis and deter- 
mined how much stiffness and fatigue the Participants were 
experiencing. In this instrument, items from the AIMS2 pain 
subscale were expanded to include level of arthritis pain 
experienced in the morning, afternoon, and evening. Other 
items were added to assess how often arthritis pain interfered 
with activities, as well as questions about the duration of pain 
in the morning and the level of pain experienced after being 
physically active. Separate sections of this instrument in- 
Table 1. Summary Statistics on Research Participants as a Function of Age 
Variable 
Gender 
Symptoms (number of health conditions) 
Average number of medications 
Number of years since diagnosist 
Disease severity rating by physician* 
Disease severity rating by participant* 
Years of education5 
Age Group 
34-44 
(n = 27) 
45-54 
(n = 33) 
55-64 
(n = 25) 
65-74 
(n = 25) 
75 + 
(n = 11) 
4 Males 
23 Females 
29.5 (22.5)* 
4.4 (1.5) 
3.7 (1.7) 
3.3 (1 .l) 
3.1 (0.7) 
3.2 (0.7) 
3 Males 
30 Females 
26.4 (15.5) 
4.3 (1.2) 
3.7 (1.7) 
3.2 (0.6) 
3.1 (0.6) 
3.2 (1 .l) 
7 Males 
18 Females 
28.9 (1 5.8) 
4.5 (1.3) 
4.1 (1.7) 
3.3 (0.7) 
3.5 (0.8) 
2.9 (1 .l) 
4 Males 
21 Females 
19.3 (13.2) 
4.0 (1 .O) 
3.2 (0.7) 
3.0 (1 .O) 
2.8 (0.9) 
3.7 (1.7) 
3 Males 
8 Females 
23.7 (1 1) 
3.7 (0.6) 
4.2 (1.3) 
3.5 (0.5) 
3.1 (0.8) 
2.6 (1 .l) 
F 
NSD 
NSD 
NSD 
NSD 
NSD 
NSD 
+l = less than one year; 2 = 1-5; 3 = 6-10; 4 = 11-15; 5 = 16-20; 6 = over 20. 
‘1 = extremely mild; 2 = mild; 3 = moderate; 4 = severe; 5 = extremely severe. 
El  = Grades 8-1 1; 2 = High School Degree; 3 = Some College; 4 = College Dcgree; 5 = Post Graduate. 
*Standard Deviations are shown in parentheses. 
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cluded similar items to determine the amount of stiffness and 
fatigue participants experienced because of their arthritis. 
Items from The Multiple Affect Adjective Checklist-Revised 
(MAACL-R) were also administered to assess level of fa- 
t i g ~ e . ~ ~  
Functional Status. Mobility, walking, hand and finger 
function, arm function, and performancc of self-care tasks, 
household tasks, and work were assessed by subscales of the 
AIMS2.21 A new summary scale was developed from the 
original AIMS2 items reflecting overall function. The pain 
and social support subscales from the original AIMS2 were 
also included. 
Mental Health. Depression and well-being were assessed 
using the Center for Epidemiological Studies Depression 
Scale (CES-D).25i26 Items from the MAACL-R were also 
completed by participants to assess levels of depression and 
anxiety.24 
Illness and Medications Beliefs 
Arthritis Beliefs Questionnaire. A detailed series of ques- 
tions regarding beliefs about rheumatoid arthritis was devel- 
oped. This instrument was based on the Health Belief Qucs- 
tionnaire by Jette et al.”; however, extensive changes to 
questions were made by the research team for use in this 
study. New items were added to assess knowledge about RA 
and its social and economic impact. Items were also revised to 
reflect the perceived severity of the participants’ disease along 
the dimensions of time course and disease cues. Because Lorig 
and  colleague^^^^^^ have shown self-efficacy to be important 
in adherence and treatment of arthritis, we elaborated on the 
self-efficacy construct by developing separatc subscales for 
different aspects of self-efficacy. These subscales addressed 
participants’ perceptions of their ability to control (a) 
disease-related negative affect, (b) the activation and mainte- 
nance of disease and associated arthritis flares, in addition to 
Lorig’s measures of (c) disease-related pain. 
Medications Use and Beliefs Questionnaire. Participants 
answered general questions about how much help they re- 
ccived in taking medications and strategies they themselves 
developed for taking medications. Participants also com- 
pleted questions about their beliefs about each of the medi- 
cations they were taking: whether the medication helped 
them; whether they rcrnembered to take it; and beliefs about 
side effects and whether it was an effective medication. These 
instrumcnts were devcloped by the research team. 
Additional questionnaires about medications and illness 
were completed for on opinions about taking medications, 
strategies for coping with arthritis, worry about illness, and 
amount of exercise. 
Contextual/Life Style Variables 
Participants completed two questionnaires in regard to 
this topic. One questionnaire was the “Busy Life Style Ques- 
tionnaire.” This questionnaire had two subscales: thc first 
subscale consisted of nine questions that assessed how cha- 
otic and unpredictable were participants daily lives (e.g., 
questions about how consistently bed times, meal times, and 
other activities were scheduled), and the second subscale was 
an 8-item “Busyness Scale” that assessed overall activity level 
(e.g., participants endorscd being so busy they couldn’t re- 
member to do  everything they had to do). The second ques- 
tionnaire had eight items, and it assessed participants’ per- 
ceptions of social support across a number of domains (e.g., 
perceived reliability and assistance from friends or family 
members). This social support questionnaire was modeled 
after previous instruments developed by McFarlane et 
and Procidano and H ~ l l e r . ~ ’  
Cognitive Assessinetit 
Participants completed a cognitive battery to assess mul- 
tiple domains of cognitive function.32 Primary among these 
were measures of speed of information p r o c e s ~ i n g ~ ~ . ~ ~  and 
on-line working memory as there is substantial 
evidence for age-related declines of these functions. Addition- 
ally, Park” has hypothesized that important cognitive com- 
ponents of medication adherence include (1) the ability to 
comprehend information present on labels, (2) reasoning and 
integrating medication instructions across prescriptions, and 
(3) long-term memory for the integrated regimen instruc- 
tions, and, thus, these domains were assessed in the cognitive 
battery. Finally, a measure of vocabulary was used to char- 
acterize the general verbal ability of our sample. A summary 
of the specific tasks used appears below. 
Speed of Processing. Two standard measures of percep- 
tual speed were administered, a Letter Comparison task and 
a Pattern Comparison task. The Letter Comparison task,35 
required participants to determine if two strings of letters 
were the same or different. Three sets of these comparisons 
were administered, each of which was comprised of either 
three, six, or nine letters. The dependent measure was the 
total number of correct decisions madc in the three 30-second 
periods. In the Pattern Comparison task:’ participants de- 
termined if geometric figures were the same or different, 
following the same format and timing as in the letter compar- 
ison task. 
Working Memory. A Reading Span task and a Compu- 
tation Span task were used to assess the on-line capacity of 
participants to simultaneously process and store information. 
The reading span task36 required participants to do three 
things. First, they were to read aloud a series of simple 
sentences that werc presented on a computer screen one at  a 
time. In addition to reading the sentence aloud, they were told 
to remember the last word in each sentence that they read. A 
third requirement was that they answer a simple question 
about each sentence. Thus subjects might read “The girl with 
the bat hit the ball.” They would be cxpected to remember 
“ball” and answer a question like “With what?’’ At the end of 
a sentence series (which ranged from two sentences to seven 
sentences), subjects would be asked to recall the words they 
had been told to remember from the sentences. There were 
three trials in each series. The number of sentences a subject 
had to hold in memory was two in the first series and then 
increased one sentence each new series up to a total of seven 
sentences. The dependent measure was the number of trials in 
which the subject both recalled the words correctly and 
answered the questions correctly. The Computation Span 
task was identical to the reading span task except that the 
stimuli were equations (ix., 2 + 4 = ?). Participants solved 
the equations (tested in a 3-item multiple-choice format) 
while holding the last digit in each equation in working 
memory. 
Text Cornprehension Meusure. Two texts from a set of 
25 structurally equivalent narrative texts specifically de- 
signed for use with older adults3’ were administered as mea- 
sures of text comprehension. The texts were presented indi- 
vidually on a computer screen and, after reading, participants 
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were asked to recall five specific details about ideas presented 
in the text without the text present. The dependent measure 
was the total number of details correctly recalled from each of 
the texts. 
Measure of Long-Term Memory. A free recall task was 
used as a measure of long-term memory. In this task, two lists 
of 25 different words each were presented to participants on 
a c~mputer.~’ Within each list of words were five categories 
of words and five exemplars presented for each category. The 
words were chosen from the Battig and Montague3* word 
norms. After the final screen from each list was presented, 
participants recalled as many items as they could in any order 
they chose. The main dependent variables were the number of 
words recalled and the number of categories accessed. 
Reasoning Measure. The Letter Sets Test39 was used as a 
measure of reasoning. Each problem in this task had five sets 
of letters with four letters in each set. Four of the sets of letters 
were alike in some way (i.e., in alphabetical order). Partici- 
pants were to find the rule that made the four sets alike and 
draw an X through the set of letters that were different. The 
participants had 7 minutes to complete 15 sets and the 
dependent measure was the number of sets completed cor- 
rectly. 
Vocabulary Measure. The Vocabulary section of the 
Shipley Institute of Living Scale4’ is comprised of 40 multiple 
choice items of increasing difficulty. The participants were 
presented with a word and instructed to choose the one of the 
four available word choices with the same, or most nearly the 
same, meaning. The dependent measure was the total number 
of correct responses. 
Procedure 
On Day 1, the participants were given a brief overview of 
the study, and their vision was assessed via a Snellen Eye 
Chart. After this, they completed a series of cognitive tests. 
When the cognitive battery was completed, the experimenter 
reviewed in detail with the participants each medication that 
was being taken (name of medication, dosage, etc.). Partici- 
pants were given empty medicine vials with plastic replace- 
ment caps and instructed to have their pharmacists transfer 
their medications into the new containers. 
Participants returned for a second and final 2-hour ses- 
sion within a week of their initial visit. Upon return, the 
participants completed the psychosocial battery in a prede- 
termined order. Participants were also provided diaries in 
which they were to note any problems with the MEMS 
system, changes in the medical regimen, or errors in using the 
MEMS system (opening the wrong medicine bottle). A fact 
sheet about the use of the MEMS caps and the diary was also 
reviewed with the participants. Participants were instructed 
to take their medications from the bottles that had been 
provided during the next 4 weeks, and whenever the MEMS 
cap was removed, the date and time the bottle was opened 
would be recorded. When the participants returned 4 weeks 
later, they turned in their medication bottles and completed a 
subset of the psychosocial battery to assess test-retest reliabil- 
ity of the instruments. 
Measuremcnt of Nonadherence 
Nonadherence rates were calculated in a stringent man- 
ner designed to ensure that patients’ behavior was not mis- 
takenly tallied as nonadherence when, in fact, patients were 
following physician instructions. Any medications that were 
prescribed as PRN (take as needed) were not included in data 
analysis. Also, during the medication interview, participants 
sometimes indicated that they took the medication on a 
different schedule from that written on the prescription sig- 
nature on the bottle, per their doctor’s oral instructions. To 
resolve this disparity, the participant’s personal physician 
was then contacted. If the physician verified the participant’s 
report, the oral instructions were used as the basis for calcu- 
lating adherence. Finally, diary notes were used to correct any 
apparent errors. For example, if a participant wrote that they 
took the medication out of the bottle and took it at a different 
time, the diary data was used to correct the data collected via 
the MEMS system. Diary notes were relatively rare and 
corrections were made less than 1% of the time (.003% of 
data points changed because of participant errors, .002% of 
data points changed because of changes in regimen by physi- 
cian). 
Weekly and biweekly adherence rates were calculated for 
each participant for each non-PRN, prescribed medication 
taken. The individual medication adherence rate was calcu- 
lated separately for each medication by dividing the total 
number of medication errors in a weekly or biweekly period 
by the total number of medication events in that period. A 
medication error occurred if a participant either omitted a 
dose of medication or took an extra dose of medication. If a 
subject took an accurate number of doses on any given day, 
they were considered adherent. Thus, if a subject took two 
doses of medications at a closer interval than that recom- 
mended by the physician (e.g., every 8 hours), or at  longer 
intervals, they would not be considered nonadherent. Nearly 
all of the errors made were omission errors. The rate for 
commission errors (taking an extra dose) was only 1.2%. 
Preliminary analyses indicated it would most useful to calcu- 
late an aggregate measure of both types of errors (omission 
and commission) that were used for all analyses, as in Morrell 
et These preliminary analyses also showed no systematic 
differences in adherence rates across types of medication (i.e., 
arthritis, NSAIDs, antihypertension, thyroid, cardiovascular, 
gastrointestinal, antidepressant, folic acid, supplements, and 
other medications), and, therefore, proportions were aver- 
aged over all medications for each participant. 
RESULTS 
Description of Nonadherence Behavior 
In the present study, a surprising 38% of the sample 
made no commission or omission errors in the month-long 
period of data collection. Perfect adherence was more com- 
mon among older than among younger adults; i.e., 47% of 
the adults older than 55 years of age and 28% of adults aged 
34 to 54 were perfectly adherent (2 = 4.75, l’ < .03). 
Participants were taking an average of 4.18 prescribed med- 
ications daily, with a mean number of 1.35 doses per day per 
medication. This is a total of approximately 170 medications 
a month taken without a single error by more than one-third 
of the overall sample and nearly half of the older adults. The 
rates of adherence across weeks are shown in Table 3. An 
analysis of variance on the weekly data, with age as a 
between-groups factor and weeks as a repeated measure 
yielded only a significant main effect of Week (F, 3, 348 = 
4.26, P < . O l ) ,  with nonadherence increasing over weeks 
(overall means of 4.6%, 5.8%, 6.6%, and 8.5% from Weeks 
1 through 4, respectively). This increase in nonadherence 
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Table 3. Average Proportion and Standard Deviation of Total Errors for Rheumatoid Sample by Weekly and Biweekly Periods 
Monitoring Period 
Age Group Week 1 Week 2 Week 3 Week 4 Biweek 1 Biweek 2 
34 -44 (n = 27) .06 (.09)* 0.05 (.08) .07 (.lo) .10 (.14) .06 (-08) .08 (.11) 
45 -54 (n = 33) .06 (.11) .09 (.14) -10 (-15) .ll (.15) .07 (-1 ) .10 (.14) 
55 -64 (n = 25) .02 (-06) .03 (.06) .06 (.12) .08 (.20) .02 (.05) .07 (.16) 
.05 (.11) .06 (.17) .04 (.14) .07 (.17) .05 (.14) .06 (.16) 65 -74 (n = 25) 
75+ (n = 11) .03 (.06) .07 (.12) .03 (.07) -04 (.06) .05 (.07) .03 (.06) 
'Standard Deviations arc shown in parentheses. 
across the monitoring period is consistent with previous 
research that has used electronic monitoring. Morrell and 
colleagues41 observed a statistically significant increase in the 
early phases of monitoring as did Park and colleagues?2 
We were particularly interested in the relationship of age 
and cognitive function to medication adherence. Because of 
the low error rates in adherence, we considered the possibility 
that we had an elite sample of older adults with exceptional 
cognitive capabilities. Thus, it was important to characterize 
the participants with respect to cognitive function. Table 4 
presents data for performance on the cognitive battery as a 
function of age, along with comparison data on the same 
measures collected from a community-dwelling, age- 
stratified sample collected by Park et al.32 and recruited from 
Table 4. Cognitive Function of Rheumatoid Sample with Comparison Data on Nonarthritis Participants from Park et al. (1996) 
Age Group 
30s 40s 50s 
Arthritis Nonarthritis Arthritis Nonarthritis Arthritis Nonarthritis 
(n = 10) (n = 44) (n = 38) (n = 45) (n = 25) (n = 41) 
Speed of processing 
Pattern comparison* 56.30 (12.5) 59.00 (8.3) 54.26 (9.6) 55.56 (9.8) 50.56 (1 0.1) 54.48 (1 0.5) 
Letter comparison* 40.30 (7.7) 41 59 (8.1) 38.87 (6.4) 36.98 (7.6) 34.28 (7.3) 35.46 (7.7) 
Computation span+ 8.40 (2.3) 9.14 (3.3) 7.37 (3.6) 7.57 (2.7) 7.40 (3.1) 7.05 (3.0) 
Reading spant 5.90 (1.9) 8.18* (2.7) 6.1 1 (2.3) 7.59 (3.0) 5.68 (2.2) 6.95* (2.6) 
Free recall* 30.90 (9.5) 31.25 (6.8) 29.34 (6.8) 30.53 (9.4) 24.76 (5.3) 27.83 (7.8) 
Shipley vocabulary§ 31.8 (5.27) 31.3 (5.6) 32.4 (4.75) 32.2 (6.8) 30.9 (5.36) 33.1 (6.5) 
Working memory 
Episodic or long-term memory 
World knowledge 
60s 70s 80s 
Arthritis Nonarthritis Arthritis Nonarthritis Arthritis Nonarthritis 
(n = 27) (n = 54) (n = 17) (n = 54) (n = 4) (n = 23) 
Speed of processing 
Pattern comparison* 45.78 (9.46) 48.78 (1 1.4) 40.41 (1 1 .l) 43.77 (8.5) 35.00 (12.3) 33.45 (8.1) 
Letter comparison* 32.59 (7.9) 32.30 (5.8) 31.82 (8.7) 30.59 (4.9) 24.00 (4.8) 23.30 (5.4) 
Computation span? 4.96 (3.08) 7.24** (3.4) 4.06 (2.1) 6.16** (2.5) 3.50 (1.7) 4.36 (3.0) 
Reading spant 5.22 (2.3) 6.72" (2.8) 4.06 (1.6) 6.20** (2.5) 3.00 (0.8) 4.61 (2.0) 
Free recall* 25.33 (7.5) 26.94 (7.8) 19.76 (7.0) 26.88** (8.2) 14.75 (7.3) 18.26 (6.7) 
Shipley vocabulary§ 30.7 (7.02) 34.5* (4.1) 31.6 (6.34) 35.6** (3.8) 31.5 (8.4) 33.6 (5.3) 
Working memory 
Episodic or long-term memory 
World knowledge 
'The dependent measure is thc total number of correct decisions made in three 30-second periods. 
'The dependent measure is the number of trails in which both the processing and storage components are correctly completed. 
*The dependent measure is the total number of words recalled from two lists of 25 words. 
STlic dcpendent measure is thc total number of correct rcsponscs to 4 0  items. 
Note. Small-sample statistical tests ( t  tests) for differences between average scores from participants in the present study and thc Park et al. sample on the cognitive 
Statistical differences between the means: *P < .05; * * P  < .01. 
measiires were performed within age group. 
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the same demographic area (Atlanta and Athens, GA). These 
data indicate two things. First, the RA sample was character- 
ized by significant age-related decline on basic processing 
abilities (speed, working memory, episodic memory, and 
reasoning), but no decline on the measure of world knowl- 
edge (Shipley vocabulary)?' One-way analyses of variance 
were conducted with age segmented by decades as the re- 
peated measures variable. All F values reported here had 4, 
120 df and significant values are .01 or greater. Both mea- 
sures of speed yielded significant age differences: F = 7.14 for 
Letter Comparison and F = 8.52 for Pattern Comparison, as 
did the two working memory measures (F = 6.008 for 
Computation Span and 4.44 for Reading Span). There was 
also a significant age effect for Free Recall (F = 6.78). How- 
ever, the F value for the Shipley Vocabulary was not signifi- 
cant (F (4,120) = 5 3 8 ,  P > .78). This pattern of decrease in 
processing abilities but invariance in world knowledge as 
measured by Shipley Vocabulary is typical in the cognitive 
aging 1iteratu1-e.~' Further evidence that the present sample 
was not elite in its cognitive abilities is that the level of 
cognitive function of the participants is roughly equivalent to 
or slightly lower than that of another age-stratified sample 
recruited from the same demographic area (Atlanta and Ath- 
ens, GA). Small sample statistical tests (t-tests) for differences 
between average scores from participants in the present study 
and the Park et al. sample on the cognitive measures were 
performed within age group. There were statistical differ- 
ences between the means (.05 or greater) for Computation 
Span and Reading Span in the subjects who were 60 and 70 
years old. In both cases, the subjects in the Park et al. sample 
evidenced performance superior to those in the present study, 
with the means shown in Table 4. The 70-year-old subjects in 
the Park et al. sample also performed significantly better than 
the subjects in the present study on Free Recall. Finally, the 
60- and 70-year-old subjects in the Park et al. sample per- 
formed significantly better on the Shipley Vocabulary Test. 
These data clearly indicate that the high levels of adherence 
evidenced in the older adults in this study cannot be attrib- 
uted to a particularly high level of cognitive functioning in the 
sample. Moreover, the excellent adherence combined with 
the clear age-related decline in cognitive processes suggests 
that normal age-related cognitive decline does not appear to 
be an important factor in understanding medication adher- 
ence in this sample of RA patients, despite many suggestions 
in the literature to the contrary. 
Structural Equation Model 
A structural equation model of adherence behavior was 
developed in order to assess the major hypotheses regarding 
the interrelationships among constructs and the relative con- 
tributions of age, cognitive ability, medical, psychosocial, 
and contextual variables to medication adherence.43 Struc- 
tural equation modeling was used to understand the predic- 
tors of adherence rather than statistical techniques such as 
multiple regression and path analysis. Unlike regression, 
structural equation modeling permits the specification of 
both direct and indirect relationships among variables, pro- 
viding more information about potential causal relationships 
than does regression analysis. Structural equation modeling 
differs from path analysis (which also permits specification of 
relationships) in that in structural models, latent variables or 
hypothetical constructs are measured by collecting multiple 
indicators of important constructs (e.g., a critical construct 
such as cognitive function or negative affect is measurcd by 
administering one or more tests or instruments that measure 
the same thing). Shared variance among these multiple mea- 
sures forms the basis for the latent construct, providing 
increased power and reliability for explaining variance in the 
target behavior (in this case, medication adherence). We used 
LISREL-8, developed by Joreskog and S0rbom,4~ a statistical 
package designed to develop structural equation models, for 
the modeling component of the analyses. 
Despite the relatively low error rate, there was neverthe- 
less sufficient variance in adherence to model it as a function 
of other predictor variables. Latent variables were con- 
structed based on theoretical considerations as well as pre- 
liminary factor analysis of questionnaires and the examina- 
tion of zero-order correlations among predictor variables. 
The outcome measure used in the structural equation model 
was nonadherence, with the data from Weeks 3 and 4 used as 
indicators of the behavior. The adherence measure was sub- 
jected to a logarithmic transformation to minimize the im- 
pact of a few extreme scores. Table 5 provides a correlation 
matrix of all of the indicators used in the model. A summary 
of the findings that guided the construction of the latent 
variable model is below. 
Medical Variables 
Preliminary analyses indicated that neither medical nor 
physical function variables were predictive of medication 
adherence. Both physician and patient self-rated measures of 
disease severity did not relate to adherence behaviors, nor did 
the number of medications patients were taking. Neither an 
unweighted or weighted version (with more serious symp- 
toms receiving heavier weights) of the physical symptoms 
check-list health scale had predictive value. Similarly, no 
subscale measures of functional capabilities from the AIMS-2 
predicted nonadherence. Self-reported measures of pain were 
also unrelated to adherence, nor did number of years since 
diagnosis relate to adherence. Thus, none of these variables 
are included in the final model. 
Cognitive Variables . 
Based on preliminary analyses and theoretical consider- 
ations, measures of speed of processing, working memory 
function, episodic memory, and reasoning were included as 
indicators of a single latent construct of general cognition. 
External Aids 
We considered whether use of external aids correlated 
with adherence as such a relationship could mask the effects 
of decreased cognitive function. There were no agc differ- 
ences in the use of external aids (e.g., use of organizers, 
writing notes, or putting the medications in a prominent 
location), nor was there a relationship between the use of 
these strategies and medication adherence. To determine if 
individuals of low cognitive ability were more likely to use 
external strategies, we compared the lower third of the sam- 
ple on cognitive ability with the rest of the sample, using t 
tests on all of the external strategy variables. The only signif- 
icant effect that emerged was that subjects with higher cogni- 
tive ability were more likely to write themselves notes as 
reminders (t(119) = 2.09, P = .04). Based on these compar- 
isons, there was little evidence that low cognitive ability 
subjects were using more environmental supports for their 
adherence and compensating for their cognitive deficits. 
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Table 5. Correlations Among Indicators in the Model 
Week 3 
MAACL-R MAACL-R Letter Working Free Busy- Mood Setf- General Total 
Age Anxiety Depression Sets Memory Speed Recall ness Control Efficacy Control Errors 
Negative affect 
MAACL-R 
Anxiety 
Negative affect 
Depression 
Letter sets 
Working memory 
Speed 
Free recall 
Busyness 
Mood control 
Self-eff icacy 
Pain control 
Week 3 Total 
errors 
Week 4 Total 
errors 
MAACL-R 
- .03 
.04 
-.45** 
-.40” 
-.51** 
- .45** 
-.28** 
.13 
-.21* 
-.15 
- .27’* 
-.15 
.84** 
-.15 
-.15 
-.13 
-.26** 
.19* 
- .61** 
-.29** 
-.23* 
.28** 
-.19* 
- .28** 
-.20* 
-.27** 
-.30** 
.05 
- .6V” 
- .29** 
-.19* 
.17 
.10 
.43** 
.54** .42** 
.51** .34** .58** 
.27* .27** .40** .21* 
.ll .15 .07 .15 -.11 
.22* .22* .17 .23* -.13 .10 
.17 .16 .28** .26* .OO .29** .02 
-02 .01 .07 -.03 .32** -.34** -.20’ -.16 
-.12 -.13 -.02 -.OO .33** -.29** -.13 -.18* .62** 
‘P c .os; **r c .001. 
We did observe, however, a weak but significant rela- 
tionship between using the specific strategy of taking medi- 
cations out of bottles and putting them into something else 
(e.g., an organizer), and medication adherence did occur (T  = 
.18, P < .04). We also found that people who reported being 
busy were somewhat more likely to report writing notes to 
remind them to take medications ( r  = .19, P = .03). Finally, 
complexity of medication regimen correlated with the pro- 
pensity to take the medications out of bottles (T  = .18, P < 
.04). None of these relationships was sufficiently strong to 
include in the model. 
ContedLife Style Variables 
The Busyness Scale was used as a measure of environ- 
mental demands and busy life style. Measures of social sup- 
port did not correlate with adherence. 
Beliefs Aboutlllness Control 
Because of the importance of beliefs about controllability 
of various aspects of disease in our theorizing and that of 
OtherS,7,10,28,29, three separate controllability constructs were 
developed, each based on a subscale of three or more ques- 
tions. The constructs were beliefs about ability to control 
pain (e.g., “I know I can manage arthritis pain so I can do the 
things I enjoy doing.”), beliefs about ability to control disease 
activity (e.g., “I think that there are lots of things I can do to 
prevent my arthritis from getting worse.”), and beliefs about 
ability to control negative moods relating to arthritis (e.g., “I 
know there are things I can do to help me feel better when my 
arthritis makes me feel blue. ”). Preliminary analyses sug- 
gested that these are independent constructs so they were 
represented in the model separately. We also examined 
whether individuals who had been diagnosed with arthritis 
longer had more knowledge about the disease. This correla- 
tion was not significant, nor was knowledge of disease related 
to adherence. 
Negative Affect 
Because beliefs about control could be related to overall 
levels of negative affect, a general construct called “negative 
affect” was included in the model, measured by the 
MAACL-R scales of Anxiety and Depression. We examined 
the measures of coping in some detail, as we had extensive 
measures of coping behavior, but we could not find any 
systematic relationships between styles of coping and adher- 
ence, nor did we see systematic relationships between coping 
styles and control. 
AModel ofAdherence Behavior 
A structural equation model was estimated using 
J o r e ~ k o g ’ s ~ ~  procedures. In constructing the model, we con- 
ceptualized age and negative affect as variables that were 
conceptually more removed from the target behavior of med- 
ication adherence and likely to have both direct and indirect 
effects on the target behavior of medication adherence (e.g., 
negative affect might directly impact on medication nonad- 
herence as well as indirectly affect other behaviors that relate 
to nonadherence). Cognitive function and contextual busy- 
ness were hypothesized to have direct effects on adherence, as 
were the various measures of disease self-efficacy. The model 
we developed is displayed in Figure 1 and, largely, confirmed 
these hypothesized relationships. The model explained 39% 
of the variance in nonadherence and had an excellent fit (2 
(56) = 70.34, P = .09, nonnormed fit index = .96, compar- 
ative fit index = .97, root-mean-square residual = .650, and 
standardized root-mean-square residual = .065). There is no 
single criterion, nor are there reference tables to assess good- 
ness of fit of structural equation models. Rather, multiple 
indicators of fit are considered jointly in assessing overall fit. 
Generally, a model that has excellent fit would have the 
following characteristics: (1) the chi-square index of fit is 
nonsignificant, indicating that the observed and estimated 
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Figure 1. A model of adherence behavior. 
models are not different; (2) the nonnormed fit index and 
comparative fit index are greater than .90 as a value of 1.0 
indicates perfect fit; (3) the standardized root-mean-square 
residual is about .05 as this is the estimate of error. The 
present model meets these criteria, particularly the goodness 
of fit criterion, with only a slightly increased error estimate 
(.065) from the desired level of .05. Table 6 presents unstand- 
ardized regression equations and standard errors for the 
model. 
The standardized coefficients are included in Figure 1. 
The model demonstrates that age, cognitive function, and 
ability to control illness-related negative moods all have 
direct paths to medication adherence. Of particular interest is 
that age has a negative relationship to nonadherence, that is, 
with increasing age, adults evidence more rather than less 
adherence. The context in which adherence occurs appears to 
be important as well, inasmuch as individuals who report 
themselves as having a very busy life have higher nonadher- 
ence rates. Although preliminary zero-order correlations in- 
dicated that cognitive function did not have a direct relation- 
ship to nonadherence, it appears that age acted as a 
suppressor for the general relationship of cognitive function 
to adherence. Thus, once the direct negative relationship of 
age to cognitive function is controlled, individuals with low 
cognitive function do show poorer adherence. With respect 
to efficacy and control, only the self-reported ability to con- 
trol negative affect associated with disease, but not control of 
pain or general disease activity, had a direct relationship to 
adherence. We did try a general model where overall arthritis 
self-efficacy (with each type of efficacy as an indicator) medi- 
ated the relationship, but the fit of this model was poor. 
General negative affect (as measured by anxiety and depres- 
sion) mediated variance in both mood and arthritis efficacy as 
well as in self-reports of busyness and general cognitive 
function. The relationships were such that high negative 
affect is related to poorer cognitive function, decreased feel- 
ings of efficacy, and higher reports of contextual engagement. 
Finally, some age-related variance in nonadherence is unex- 
plained by any variables in the model because age exerts a 
direct effect on nonadherence in addition to the strong age 
path operating through cognition. 
Overall, this model demonstrates powerful relationships 
of cognitive, contextual, and affective variables to medication 
nonadherence. We were unable to establish any relationships 
involving traditional medical variables - such as symptom- 
atology, number of medications, or disease severity - to 
medication nonadherence. The model suggests that the pro- 
file of a nonadherent individual with rheumatoid arthritis 
would most likely be a middle-aged adult of lower cognitive 
ability who reports being very busy or contextually engaged, 
has some anxiety/depression, and believes they have little 
ability to control negative affect associated with disease 
s ymptomatology. 
DISCUSSION 
The present findings make a number of important points 
that have largely been unrecognized in understanding patient 
adherence to a medical regimen. First, age is indeed a risk 
factor for nonadherence, but it is younger rather than older 
adults who are more at  risk for making medication errors. 
Despite the suggestion that older people have a high nonad- 
herence rate because of cognitive dysfunction, our data indi- 
cate clearly that maintaining a medication regimen does not 
impose a cognitive load that is so high that older adults have 
insufficient cognitive function to adhere accurately. The data 
show that older adults evidenced significant cognitive decline 
relative to younger adults but still had sufficient cognitive 
resources to take medication with an extraordinary degree of 
accuracy. This finding is largely in agreement with that re- 
ported by Park and colleagues42 and Morrell and col- 
Table 6. Unstandardized Maximum Likelihood Estimatcs for the Structural Model 
Negative Arthritis Mood Pain 
Variable Age Affect Cognition Busyness Efficacy Control Control 
Negative affect .004 (.030)+ 
Cognition -.099*** (.015) -.167*** (.045) 
Busyness .424** (.136) 1.456*** (3.10) 
Arthritis efficacy -.078* (.031) 
Mood control .030* (.012) -.360*** (.046) .305* (.125) 
Pain control -.024* (.010) -.116** (.033) 
Adherence -.013** (.005) -.089* (.037) .036"* (.008) -.050** (.020) 
Note: ' P  < .05; * * P <  .01; * * * P  < .001. 
+Standard Errors shown in parentheses. 
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leagues41 as both studies report very high adherence for 
adults ages 60 to 75. 
The high adherence rates in the older RA patients is likely 
due to vigilance about their health because RA is a serious 
illness with many symptoms that can interfere with daily 
function. Leventhal et al.45 noted more vigilance in monitor- 
ing health and seeking health care in older compared with 
younger adults. This vigilance may prevent them from getting 
into risky situations that require complex care and medical 
interventions if they are left untreated:6 We have noted in 
working with older patients, particularly those with a serious 
illness such as RAY that the patients frequently structure their 
daily activities around their medication schedules rather than 
the reverse. These experienced, older users of medication are 
in contrast to younger adults, who tend to fit medication 
events into their daily schedules. The finding that individuals 
who report being very busy were the most nonadherent 
supports such an interpretation. It would appear that very 
busy people are essentially operating under high memory 
load conditions with many tasks and situations simulta- 
neously competing to capture their attention. Remembering 
to take medication for these individuals becomes problem- 
atic, not because they have insufficient cognitive function to 
perform the task, but because little of their cognitive resource 
is being devoted to the task of remembering to take medica- 
tions. The busyness finding does not allow us to make infer- 
ences about what type of memory is most affected by being 
busy. Busy individuals may not take the time to understand or 
learn their drug regimen, which would point to problems in 
comprehension or long-term memory. Or busy people may 
both understand and remember what it is they are to do but 
have trouble with the prospective component, that is, remem- 
bering to take the drug at  the time they are supposed to take 
it. Thus, more work is required to understand what the 
cognitive underpinnings of this effect are. Another explana- 
tion for the relationship of being busy to poor adherence is 
that busy people have little time to muse or think about their 
illness and do  not have a representation of their illness that 
leads to a motivation to take the medication. However, the 
memory explanation seems more likely because we did not 
find evidence that busy people have different belief structures 
regarding their illness. In sum, the data suggest that being a 
very busy person mitigates against accurate use of medication 
because of an overly full life that leaves little time to attend to 
health concerns. In contrast, being old does not put one at  
risk of nonadherence, in part because older people may be 
less busy in their daily lives and have more time to devote to 
health concerns. 
Another important finding from the present study is the 
overall high rate of medication adherence observed in the 
entire sample. Participants were much more accurate in their 
use of medications than has been suggested in the RA litera- 
ture, where less accurate means of monitoring have been 
used. Thirty-eight percent of patients made no mistakes at  all 
in their complex regimens throughout a 1-month period of 
observation! 
It is, therefore, relevant to emphasize that the present 
sample of RA patients was somewhat positively selected with 
respect to functional limitations imposed by RA (e.g., re- 
stricted mobility) and with respect to exclusion criteria (self- 
vs other-administered medications) that would limit repre- 
sentation of individuals with the most severe impairments. 
Clearly this aspect of the study would also tend to exclude 
extremely ill, frail, homebound older patients who might be 
at  greatest risk for nonadherence. Thus, our generalizations 
regarding a lack of effect of age-related cognitive decline are 
limited to what is termed normal or primary aging and would 
not necessarily characterize cognition-related adherence def- 
icits in RA patients with co-occurring dementia or other 
major pathologies that would limit ability to care for oneself. 
There are other aspects of the study that may have acted 
to enhance adherence rates relative to other studies. This 
study assessed volunteer patients who were aware that their 
behavior was being observed, which may have enhanced 
adherence. Moreover, RA is a serious illness, which provides 
frequent feedback, in the form of pain and decreased mobil- 
ity, for which medication is needed. This no doubt serves to 
enhance medication adherence for RA relative to other dis- 
eases. Morrell et observed higher rates of adherence 
errors in hypertension patients who receive no physical feed- 
back about their condition. Additionally, the decision to 
screen carefully and exclude PRN medications, as well as to 
resolve differences between physicians' verbal instructions 
and instructions on the prescription signature, may have 
resulted in a lower estimate of errors than has been reported 
by others. Finally, it is important to note that we studied 
experienced medication users, who were in treatment for 
their disorder. Higher rates of nonadherence may be found in 
inception samples if they are followed from initial diagnosis. 
Such samples are more likely to include a subset of patients 
who receive diagnosis of a disorder such as RA but do not 
take prescribed medication and seek no further treatment. 
It is interesting that constructs such as perceptions of 
illness, self-efficacy beliefs, and other psychosocial variables 
that others have hy othesized to be important in understand- 
ing a d h e r e n ~ e ' ~ * ~ " * ~ ~  appear not to have played a strong role 
in the RA patients' adherence. It may be the case that the 
importance of these variables depends on the kind of disease 
process that is under treatment. The impact of the relation- 
ship of these variables, although not important in the present 
study and sample, might be significant in samples with very 
high rates of nonadherence or for disorders that are silent, 
such as hypertension, or for diseases where the perceived and 
actual consequences of nonadherence are less compelling 
(ix., osteoarthritis):' In these cases, one might expect beliefs 
and emotional status to be more important. 
Although the data make a strong case that older adults 
are at  low risk for taking medications incorrectly, the cogni- 
tive model of medication adherence is not invalidated by the 
present data. There was a significant path from general cog- 
nitive function to nonadherence once the variance in cogni- 
tive function caused by age was removed, as shown in the 
model displayed in Figure 1. This finding suggests that indi- 
viduals of low cognitive status relative to others their own age 
will have more problems taking medication accurately. In 
other words, a younger adult of low ability, or an older adult 
who has low ability relative to others their own age, will be at  
some risk of nonadherence. This is an important finding 
because it indicates that laboratory measures of cognitive 
function, when considered in context as is the case with the 
present modeling techniques, can explain variance in impor- 
tant every day behaviors. This finding also points to problems 
with comprehension and long-term memory rather than pro- 
spective memory (remembering when to take a medication) 
as the basis for the nonadherence in low-ability adults. The 
items used to form the cognitive variable are associated with 
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comprehension and long-term memory, but not prospective 
memory, suggesting that additional time spent making sure 
low ability individuals comprehend their drug regimen would 
be worthwhile. 
It is important to consider the clinical implications of the 
present findings. These data suggest that an individual who 
was highly adherent would most likely be old (contrary to 
popular memory stereotypes of older people), less busy, have 
high positive affect, and would believe that he/she could 
control any depression and anxiety associated with the dis- 
ease. The clinical profile of a nonadherent individual would 
be a very busy, somewhat unhappy, young or middle-aged 
adult of low cognitive ability. An effective intervention for 
nonadherence for such an at-risk individual could take mul- 
tiple forms. First, a physician could prescribe simpler drug 
regimens whenever there was a choice for an at-risk individ- 
ual and ask staff to spend more time educating the patient 
about hidher condition, when he/she was to take the medi- 
cations, and determine that the patient comprehended what 
to do. Second, for a complex regimen, it would be worthwhile 
to consider providing a medication organizer, but care needs 
to be taken to see that the patient knows how to load it 
correctly. Park and colleagues4* reported that arthritis pa- 
tients made errors in loading organizers; but if it is loaded 
correctly, Park et a1.42 found that organizers improved med- 
ication adherence in older adults. Finally, it might be worth- 
while to consider using an external reminding device, such as 
a beeping wristwatch, to remind the patient to take their 
medications, an intervention that Park, Shifren and col- 
leagues found to be effective with hypertensive patients.49 
In closing, this pattern of findings makes a strong case for 
considering that the context in which illness occurs, as well as 
the nature of the illness itself, is important in understanding 
adherence behaviors. Individuals with a less painful disease, 
one in which clinical symptoms are less well controlled by 
medications, might well present a different profile. Neverthe- 
less, our data indicate clearly that nondemented older adults 
appear to have all of the features necessary to be adherent. 
Although we found strong evidence for normative age-related 
decline in cognitive function, the baseline level of cognitive 
ability was still easily sufficient to adhere to a complex 
regimen. 
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